EFPIA launches Manifesto for an Integrated Life Sciences Strategy for Europe

5 May 2014
eu-big

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has today announced the launch of its Manifesto for an Integrated Life Sciences Strategy in Europe, aimed at promoting a healthier future for Europe and its citizens.

Economic recession and austerity policies have compromised Europe’s healthcare systems, while deepening access inequalities across the European Union. As Europe begins to emerge from the financial crisis and sets out its plans for a return to growth, the time is right to fundamentally review how Europe can improve the health prospects of citizens, while also promoting economic growth. the EFPIA’s vision of an integrated innovative life sciences sector for Europe offers a solution.

Christopher Viehbacher, chief executive of French drug major Sanofi and president of the EFPIA, stated: “Innovation is the key to improving health across Europe. Now is the time for Europe to act. A thriving life sciences sector will deliver innovative solutions to tackle future health care challenges and we all know that a healthier population will drive economic growth. Equally, we need to rebuild sustainable health care systems, improve access to existing and future solutions and do a better job at preventing and treating chronic disease through technological, behavioural and therapeutic innovations such as outlined in the EFPIA Manifesto.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical